Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011851
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alzheimer’s Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation that offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. The foundation offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. It offers grants to the recipients for the treatment of Alzheimer’s disease. The foundation offers funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer’s Drug Discovery Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Partnerships 13
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer’s Disease Drugs 13
Equity Offering 14
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer’s Drug Discovery Foundation – Key Competitors 15
Alzheimer’s Drug Discovery Foundation – Key Employees 16
Alzheimer’s Drug Discovery Foundation – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 18
Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 19
Product News 20
Jun 07, 2017: The Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 20
Other Significant Developments 21
Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer's Drug Discovery Foundation, Key Competitors 15
Alzheimer's Drug Discovery Foundation, Key Employees 16

★海外企業調査レポート[Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • TUV Rheinland AG:企業の戦略的SWOT分析
    TUV Rheinland AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Edenred SA (EDEN):企業の財務・戦略的SWOT分析
    Edenred SA (EDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • United Parcel Service Inc (UPS):企業の財務・戦略的SWOT分析
    United Parcel Service Inc (UPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ZIL Ltd:企業の戦略・SWOT・財務分析
    ZIL Ltd - Strategy, SWOT and Corporate Finance Report Summary ZIL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • REVA Medical Inc (RVA):企業の財務・戦略的SWOT分析
    Summary REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It off …
  • Hindustan Construction Co Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ConceptoMed AS-医療機器分野:企業M&A・提携分析
    Summary ConceptoMed AS (ConceptoMed) is a medical device manufacturer that offers medtech products. The company's products comprise medical syringe and needle, medical tools, Luer-Jack, ConceptoShield, and disposable medical instruments and devices. ConceptoMed also offers epidural injections, plexu …
  • WPG Resources Ltd (WPG):企業の財務・戦略的SWOT分析
    Summary WPG Resources Ltd (WPG) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, nickel, base metals, iron ore, and coal properties in South Australia. Its projects comprise Tunkillia gold project, Tarcoola gold …
  • Teladoc Health Inc (TDOC):医療機器:M&Aディール及び事業提携情報
    Summary TelaDoc Health Inc (Teladoc Health) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold …
  • Enercon Services Inc-エネルギー分野:企業M&A・提携分析
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • Sequella Inc-医療機器分野:企業M&A・提携分析
    Summary Sequella Inc (Sequella) is a clinical-stage pharmaceutical company that develops and commercializes small molecule and natural product-based therapeutics for the treatment of infectious diseases. The company’s product pipeline include SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid anti …
  • Compagnie Plastic Omnium SA (POM):企業の財務・戦略的SWOT分析
    Compagnie Plastic Omnium SA (POM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Misawa Homes Co., Ltd.:戦略・SWOT・企業財務分析
    Misawa Homes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Misawa Homes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Civitas Solutions, Inc.:企業の戦略・SWOT・財務情報
    Civitas Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Civitas Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hess Corporation:企業の戦略・SWOT・財務分析
    Hess Corporation - Strategy, SWOT and Corporate Finance Report Summary Hess Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆